NVCT: Nuvectis Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 178.24
Enterprise Value ($M) 159.71
Book Value ($M) 9.71
Book Value / Share 0.42
Price / Book 18.35
NCAV ($M) 9.71
NCAV / Share 0.42
Price / NCAV 18.35

Profitability (mra)
Return on Invested Capital (ROIC) -1.96
Return on Assets (ROA) -0.99
Return on Equity (ROE) -1.56

Liquidity (mrq)
Quick Ratio 2.09
Current Ratio 2.09

Balance Sheet (mrq) ($M)
Current Assets 18.61
Assets 18.61
Liabilities 8.89
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -19.85
Net Income -19.00

Cash Flow Statement (mra) ($M)
Cash From Operations -12.25
Cash from Investing 0.00
Cash from Financing 11.65

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-05 13G/A Pontifax Management 4 G.p. (2015) Ltd. 1.50 -68.51
2024-02-28 13G/A Mosseri Marlio Charles 15.00 9.03

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-05 10-Q On the Microsoft license do we have access to UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 27,917 84,304 33.11
2025-03-10 44,381 164,157 27.04
2025-03-07 22,543 81,533 27.65
2025-03-06 28,205 87,487 32.24

(click for more detail)

Similar Companies
NLSP – NLS Pharmaceutics AG NRSN – NeuroSense Therapeutics Ltd.
NRXP – NRx Pharmaceuticals, Inc. OCEA – Ocean Biomedical, Inc.
OCGN – Ocugen, Inc.


Financial data and stock pages provided by
Fintel.io